ExLibris header image
SFX Logo
Title: Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs
Source:

BMC Medical Genetics [1471-2350] yr:2014


Collapse list of basic services Basic
Full text
Full text available via DOAJ Directory of Open Access Journals
GO
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Tod, M. "Quantitative prediction of the impact of drug interactions and genetic polymorphisms on cytochrome P450 2C9 substrate exposure." Clinical pharmacokinetics 52.3 (2013): 199-209. Link to SFX for this item
2. Ojha, A. "A REVIEW ON THE ROLE OF PHARMACOGENOMICS IN DRUG DISCOVERY AND DEVELOPMENT." International Journal of Pharmaceutical Sciences and Research 7.9 (2016): 3587-3595. Link to SFX for this item
3. Kamdem, L. "Clinical implications of CYP3A polymorphisms." Expert Opinion on Drug Metabolism and Toxicology 2.2 (2006): 171-182. Link to SFX for this item
4. Tod, M. "Quantitative Prediction of Cytochrome P450 (CYP) 2D6-Mediated Drug Interactions." Clinical pharmacokinetics 50.8 (2011): 519-30. Link to SFX for this item
5. Lagassé, H A Daniel A. "Recent advances in (therapeutic protein) drug development." F1000Research. 6: 113-113. Link to SFX for this item
6. Asensi, V. "Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics." World Journal of Virology 4.3 (2015): 169-77. Link to Full Text for this item Link to SFX for this item
7. Gao, Bruno o. "Drug Transporters in the Central Nervous System." Clinical pharmacokinetics 54.3 (2015): 225-242. Link to SFX for this item
8. Tulsyan, S. "Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy." Clinica chimica acta 434 (2014): 21-28. Link to SFX for this item
9. Goutelle, S. "In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates." The AAPS journal 15.2 (2013): 415-26. Link to Full Text for this item Link to SFX for this item
10. Chen, S. "Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism - a prospective, randomized, controlled study." Clinical transplantation [record in progress].3 (2013): 272-81. Link to SFX for this item
11. Eijk-Van Os PG, Jan G. "Multiplex Ligation-dependent Probe Amplification (MLPA(R)) for the detection of copy number variation in genomic sequences." Methods in molecular biology 688 (2011): 97-126. Link to SFX for this item
12. Wang, J. "CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation." Expert Review of Molecular Diagnostics 9.4 (2009): 383-90. Link to SFX for this item
13. Surendiran, A. "Role of pharmacogenomics in drug discovery and development." Indian journal of pharmacology 40.4 (2008): 137-143. Link to Full Text for this item Link to SFX for this item
14. Wilkinson, G R R. "CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism." Clinical pharmacology and therapeutics 68.1 (2000): 82-91. Link to SFX for this item
15. Ingelman-Sundberg, M. "Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms." Naunyn-Schmiedeberg's archives of pharmacology 369.1 (2003): 89-104. Link to Full Text for this item Link to SFX for this item
16. Mehlotra, Rajeev K K. "Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea." European journal of clinical pharmacology 62.4 (2006): 267-275. Link to Full Text for this item Link to SFX for this item
17. Roses, Allen D. "Pharmacogenetics in drug discovery and development: a translational perspective." Nature reviews. Drug discovery 7.10 (2008): 807-817. Link to Full Text for this item Link to SFX for this item
18. "Inform elders about grapefruit juice." ED nursing 13.9 (2010): 102-102. Link to SFX for this item
19. Zhou, Zhou F. "Polymorphism of human cytochrome P450 2D6 and its clinical significance:" Clinical Pharmacokinetics 48.12 (2009): 761-804. Link to SFX for this item
20. Davies, Benjamin J., B. "Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexiline." British journal of clinical pharmacology 65.3 (2008): 347-354. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced